Emlyn Samuel

Cancer Research UK
Head of Policy Development

Emlyn leads the policy development team at Cancer Research UK. His team is responsible for developing the charity''''s position on areas of public policy on a range of issues. This includes the how Government can support a thriving research environment, how cancer services are run - to diagnose patients earlier and provide better access to treatment - and how charity laws should be reformed.

His previous roles include policy positions at the Wellcome Trust, The Academy of Medical Sciences, and a secondment to the Office for Life Sciences to support the development of the Life Sciences Industrial Strategy.

dont miss

Brexit: getting the best outcome for research and patients

This seminar will discuss Cancer Research UK’s policy work on Brexit, including evidence about the impact of UK-EU collaboration and what our priorities are for negotiations about the future relationship between the UK and EU.

EVEN MORE SEMINARS

  • Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath: Speaking at the Oncology Convention

    Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath
    University Hospital Southampton NHS Foundation Trust.

    Targeted therapies: aiming at the tumour micro-environment

  • Chris Curtis: Speaking at the Oncology Convention

    Chris Curtis
    The Swallows Head & Neck Cancer Charity

    A patient’s journey ‘Cancer to the palace in 6yrs’

  • Sam Janes: Speaking at the Oncology Convention

    Sam Janes
    UCL

    Early Detection of Lung Cancer

  • Professor David Maintz: Speaking at the Oncology Convention

    Professor David Maintz
    University Hospital Cologne, Department of Radiology

    Spectral CT: Dual layer technology helps to increase diagnostic confidence

  • Professor Alex Mirnezami: Speaking at the Oncology Convention

    Professor Alex Mirnezami
    University of Southampton

    Biomarkers of Epithelial to Mesenchymal Transition and their clinical relevance in colorectal cancer